Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published February 2013
  • Article
  • Info & Metrics
  • PDF
Loading

Going Vegan Confers the Most Cancer Protection among Different Vegetarian Diets

Tantamango-Bartley et al. Page 286

Approximately 30% of all cancers in developed countries can be attributed to diet and nutrition. This prospective study compares the association of several distinct vegetarian diet subtypes with non-vegetarian diets for overall cancer incidence. The strongest inverse correlation with diet and cancer comes with the analyses of gastrointestinal and a female-specific cancer. Little benefit in diet was seen for respiratory tract cancers. Vegan diets exhibited the most potent effect in decreasing overall cancer incidence as well as exhibiting the most significant decrease in female-specific cancers. Although the results confirm that vegetarian diets confer protection, some diets are clearly more effective than others and some cancers are more sensitive to diet than others. The significant results from this preliminary analysis awaits longer follow-up to provide additional numbers of cancers and cancer subtypes.

Endometrial Cancer Susceptibility Linked to Genes Associated with Inflammation

Delahanty et al. Page 216

Among the many risk factors associated with endometrial cancer, genetics plays a prominent yet undefined role. Chronic inflammation has been known to be a critical component in the susceptibility to cancer. The current report provides intriguing links between genetic polymorphisms in genes linked to inflammation and endometrial cancer risk. In this analysis, the investigators identified 24 loci linked to the inflammatory process in stage 1 and confirmed that 2 loci were significantly associated with endometrial cancer in a larger, more comprehensive stage 2 analysis. The results confirmed the hypothesis that genetic polymorphisms in genes linked to the inflammatory pathway may contribute to the genetic susceptibility to endometrial cancer.

Adipokines, Obesity, and Breast Cancer

Santana et al. Page 270

Obesity is a well-established risk factor for the development of breast cancer and a poor prognostic indicator. It has been demonstrated that white adipose fat is a potent source of bioactive proteins. Santana and colleagues explored the link between levels of the acute phase protein, serum amyloid A (SAA), obesity, and breast cancer in postmenopausal women. This study identified a significant positive correlation between levels of SAA and the cancer patients' body mass index. The levels of SAA were higher in the more aggressive and worse prognostic ER− cancers in comparison with ER+ cancers. Larger studies will be needed to determine the usefulness of SAA as a biomarker aggressive breast cancer.

Risk of Developing Lymphoma in HIV-Infected Patients Linked to Levels of a Chemokine

Hussain et al. Page 295

B-cell non-Hodgkin lymphoma is the most commonly diagnosed cancer amongst HIV-infected people. Identifying the at-risk population should provide a great benefit to facilitate monitoring and early treatment. The study presented by Hussain and colleagues suggests that serum levels of the chemokine CXCL13 might be that critical biomarker. The results demonstrate that there is a significant increase in serum levels of CXCL13 in non-Hodgkin lymphoma HIV-infected patients as early as 3 years before lymphoma diagnosis. Haplotype analysis failed to identify a significant linkage between CXCL13 or CXCR5 polymorphisms and increased expression; however, one CXCL13 allele was shown to have a protective influence in both serum levels and lymphoma risk. These results reveal a link between CXCL13 expression and lymphoma development.

  • ©2012 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (2)
February 2013
Volume 22, Issue 2
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev February 1 2013 (22) (2) 179;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev February 1 2013 (22) (2) 179;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Going Vegan Confers the Most Cancer Protection among Different Vegetarian Diets
    • Endometrial Cancer Susceptibility Linked to Genes Associated with Inflammation
    • Adipokines, Obesity, and Breast Cancer
    • Risk of Developing Lymphoma in HIV-Infected Patients Linked to Levels of a Chemokine
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement